Getinge AB (OSTO:GETI B)
kr 222.6 1.7 (0.77%) Market Cap: 60.63 Bil Enterprise Value: 66.95 Bil PE Ratio: 23.33 PB Ratio: 1.90 GF Score: 86/100

Q2 2022 Getinge AB Earnings Call Transcript

Jul 19, 2022 / 08:00AM GMT
Release Date Price: kr229.6 (-2.51%)
Operator

Good morning, and welcome to the Getinge AB conference call. (Operator Instructions) After today's presentation, there will be an opportunity to ask questions. (Operator Instructions) Please note this event is being recorded.

We have with us Mr. Mattias Perjos, CEO; and CFO, Lars Sandstrom. I'd now like to turn the conference over to Mattias Perjos, CEO. Sir, please go ahead.

Mattias Perjos;publ;CEO
Getinge AB;President & Director

()- -

Thank you very much, and thanks, everyone, for joining today's conference call, and we can move directly into Page #2, please, and I will go through some of the key takeaways from the second quarter. So as expected, we saw a decline when it comes to order intake and net sales, which decreased by 5% to 7.5% organically in the quarter. One bright spot here though was that the order intake increased towards the end of the quarter, so an indication of better momentum going forward.

The development for the quarter as a whole was affected by reduced production of vaccines

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot